William H. Rastetter
Director at Neurocrine Biosciences; Director at Iambic Therapeutics; Director at Fate Therapeutics. Based in San Diego, California.
- Rank
- 8559th of 14,452
- Companies held
- 4
- Largest holding
- NBIX, 65.9% of total
- Latest SEC filing
- Oct 16, 2026
What the $10.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Neurocrine Biosciences NBIX Common Stock | Directly | 43,678 | $156.59 | $6.8M | 65.9% | Form 4, May 21, 2026 |
| Iambic Therapeutics IAM Common Stock | Through Rastetter Family Trust | 200,920 | $14.26 | $2.9M | 27.6% | Form 4, Oct 16, 2026 |
| Fate Therapeutics FATE Common Stock | Through The Investment 2002 Trust, dated 11/11/02 | 459,272 | $1.01 | $464K | 4.5% | Form 4, May 5, 2026 |
| Fate Therapeutics FATE Common Stock | Through The Rastetter Family Trust, dated 09/02/10 | 146,821 | $1.01 | $148K | 1.4% | Form 4, May 5, 2026 |
| Fate Therapeutics FATE Common Stock | Directly | 36,331 | $1.01 | $37K | 0.4% | Form 4, May 5, 2026 |
| Daré Bioscience DARE Common stock | Directly | 39,721 | $0.45 | $18K | 0.2% | Form 4, Jun 30, 2026 |
Share counts are the amounts William H. Rastetter reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8556 | Glenn Henry Stevens Insider, StoneX Group. New York, NY | $10.4M |
| 8557 | David Kieske Chief Financial Officer, VICI Properties. Los Angeles, CA | $10.4M |
| 8558 | Emile Haddad Director, Five Point Holdings, LLC. Irvine, CA | $10.4M |
| 8559 | William H. Rastetter Director, Neurocrine Biosciences. San Diego, CA | $10.4M |
| 8560 | Elizabeth A. Barrett Chief Executive Officer, UroGen Pharma. Princeton, NJ | $10.4M |
| 8561 | Douglas N. Currault II EVP & General Counsel, Freeport-McMoRan. Phoenix, AZ | $10.4M |
| 8562 | Mithun Banarjee Chief Customer Officer, Workiva. Ames, IA | $10.4M |
Other Neurocrine Biosciences insiders
All NBIX insiders- Kevin Charles Gorman$81.1MDirector. #1758 overall
- Kyle Gano$24.3MChief Executive Officer. #4475 overall
- Gary A. Lyons$19.1MDirector. #4752 overall
- Eric Benevich$10.5MChief Commercial Officer. #8450 overall
- Darin Lippoldt$8.9MChief Legal Officer. #9599 overall
- Eiry Roberts$8.0MChief Medical Officer. #9979 overall
Questions
How much stock does William H. Rastetter own?
William H. Rastetter holds $10,371,459 in listed stock based on SEC filings and current prices, mostly Neurocrine Biosciences (NBIX). That ranks 8559th on the Stock Rich List.
Is this William H. Rastetter's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did William H. Rastetter last buy or sell stock?
The most recent open-market trade on file is a sale of 18,000 NBIX shares on Nov 5, 2025 at $151.82.